Hospital news

Monday, June 5, 2023 Drug prolongs time before brain tumour grows back

As part of the Phase 3 clinical trial, research participants with low-grade gliomas, taking the drug vorasidenib remained free from tumour re-growth for 27.7 months, as of the time of study read-out.

Monday, May 29, 2023 Announcing the 2023 Sunnybrook Excellence in Education Awards

The 2023 Sunnybrook Excellence in Education Awards honours nine champions of education.

Wednesday, May 24, 2023 Sunnybrook scientists awarded CIHR funding to research mpox and other zoonotic diseases

CIHR’s Centre for Research on Pandemic Preparedness and Health Emergencies is providing funding for eleven of the mpox projects, while the HIV/AIDS and Sexually Transmitted and Blood Borne Infections (STBBI) Research Initiative is funding two projects.

Saturday, May 20, 2023 Study shows high-dose radiation treatments safe and well-tolerated by women with uterine cancer

Thursday, May 18, 2023 Sunnybrook's Tory Trauma Program first outside U.S. to be verified as a level 1 trauma centre by the American College of Surgeons

Sunnybrook is the first hospital outside of the U.S. to achieve this standard

< 9 10 11 12 13 14 15 >